Post by Targeted Oncology

What factors are shaping first-line treatment decisions for patients with EGFR-mutated advanced NSCLC? In our latest Investigator Perspectives video series, Misako Nagasaka, MD, PhD shares practical perspectives on interpreting emerging clinical evidence, selecting appropriate first-line therapies, and applying new data to real-world patient care. Watch the series to hear expert insights that can help inform your clinical decision-making: https://hubs.li/Q04nCr400 #Oncology #LungCancer #NSCLC #EGFR